SCIENTIFIC PHARMACEUTICAL RESEARCH

Brand Owner (click to sort) Address Description
EXIS Prellis Biologics, Inc. 3944 Trust Way Hayward CA 94545 Scientific and pharmaceutical research, development, engineering and testing services in the fields of viral related diseases and disorders, immunopharmaceuticals, antibodies, and treatments of tumors, namely, research, development, and testing of pharmaceutical products; scientific and pharmaceutical research, development, engineering and testing of prophylactic treatments of viral related diseases and disorders, namely, research, development, and testing of pharmaceutical products;
TRAVECTA Travecta Therapeutics Pte Ltd. Level 06, Unit 01 79 Science Park Dr., 08 Cintech IV Bldg. Singapore 118264 Singapore Scientific and pharmaceutical research and development services in the field of disorders and conditions of the central nervous system, namely, research and development services in connection with identifying, categorizing, and delivering molecules to the brain; scientific and pharmaceutical research and development services in the field of cancer prevention and treatment;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A bacterial ?1,3-fucosyltransferase gene and deduced amino acid sequence is provided. The gene is useful for preparing ?1,3-fucosyltransferase polypeptide, and active fragment thereof, which can be used in the production of oligosaccharides such as Lewis X, Lewis Y, and siayl Lewis X, which are structurally similar to certain tumor-associated carbohy-drate antigens found in mammals. These product glycoconjugates also have research and diagnostic utility in the development of assays to detect mammalian tumors. In addition the polypeptide of the invention can be used to develop diagnostic and research assays to determine the presence of H. pylori in human specimens.